XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.2
Intangible Assets and Goodwill (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 22, 2019
Jul. 31, 2017
Apr. 30, 2017
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Jan. 31, 2019
Goodwill       $ 4,751,055   $ 4,751,055    
Amortization of identifiable intangible assets       $ 12,896 $ 8,561 $ 25,737 $ 8,561    
Autotelic Inc., [Member]                  
Shares issue price                 $ 4.00
Merger Agreement [Member]                  
Goodwill [1] $ 4,751,055                
Aggregate purchase price 3,727,752                
Merger Agreement [Member] | Oncotelic [Member]                  
Goodwill $ 4,751,055                
License Agreement [Member] | Oncotelic [Member] | Adhera Therapeutics, Inc. [Member]                  
Shares to be issued during the period for acquisition   49,019              
Aggregate purchase price   $ 250,000              
Shares issue price   $ 5.10              
Agreement term, description   Stock Purchase Agreement to be entered into between us and Adhera within thirty (30) days following the date of the License Agreement.              
Agreement termination date, description   As of May 2018, we had not completed the purchase of the stock and were not able to reach to a definitive agreement, and as part of the Omnibus Settlement Agreement, entered into on October 1, 2018, between Adhera, Vuong Trieu, Ph.D. and affiliated entities, the License Agreement was terminated effective May 15, 2018.              
Assignment and Assumption Agreement [Member] | Oncotelic [Member]                  
Previously billed charges wrote off               $ 458,000  
Assignment and Assumption Agreement [Member] | Autotelic Inc., [Member]                  
Shares issued during the period for acquisition, shares     204,798            
Shares issued during the period for acquisition     $ 819,191            
[1] The primary items that generate goodwill include the value of the synergies between the acquired company and Oncotelic, Inc. and the acquired assembled workforce, neither of which qualifies for recognition as an intangible asset. Goodwill is the excess of the purchase price over the fair value of the underlying net tangible and identifiable intangible assets. In accordance with applicable accounting standards, goodwill is not amortized but instead is tested for impairment at least annually or more frequently if certain indicators are present. Goodwill and intangibles is not deductible for tax purposes. The Company has considered the valuation as a preliminary allocation of assets and liabilities and may adjust such estimates in the future, if deemed material.